OBJECTIVE: To examine the prevalence and management of @entity2316 in a @entity6 clinic. RESEARCH DESIGN AND METHODS: Characteristics of @entity8518 identified by existing screening practice (phase I, @entity633 >20 mg/l in three separate urine samples), were compared with those identified by a nurse-led management program (phase II, in which screening for @entity8 was based on albumin-to- @entity1011 ratio in a single random urine specimen). RESULTS: In phase I, 644 @entity1 attended a @entity6 clinic over a 6-month period. Microalbuminuria results were available for 485 @entity1 (75%). A total of 115 @entity1 were identified as @entity8518 (prevalence 17.8%). Of these @entity1 , 91% had type 2 @entity6 . During phase II, prospective analysis of urinary albumin-to- @entity1011 ratio was carried out in 880 @entity1 over 8 months. A total of 174 @entity1 were identified as @entity8518 (prevalence 20%). Of these, 134 @entity1 had been identified by existing screening protocols. Forty had no previous record of microalbuminuria and were therefore newly identified by prospective screening. Systolic blood pressure guidelines were met in only 31% of all known @entity8518 and 26.5% of newly diagnosed @entity8518 . Diastolic blood pressure guidelines were met in 36% of all known and 38% of newly diagnosed @entity8518 . In the @entity1 group of known @entity8518 from phases I and II, 62% were prescribed ACE inhibitors (ACEIs) or angiotensin II receptor (AIIR) antagonists. In the newly identified @entity8 @entity1 cohort from phase II, 48% used ACEIs or AIIR antagonists. CONCLUSIONS: Introduction of a nurse-led management program significantly improved detection of @entity8 . We are currently evaluating its impact on clinical management.

Identification and management of XXXX in the @entity6 clinic.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity8 :: ('MESH:D007674', 'Disease') :: ['nephropathy'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity2316 :: ('MESH:D003928', 'Disease') :: ['diabetic nephropathy'] @entity633 :: ('MESH:D000419', 'Disease') :: ['albuminuria'] @entity8518 :: ('MESH:D003554', 'Disease') :: ['nephropaths'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine']
@entity2316 :: (MESH:D003928,Disease) :: ['diabetic nephropathy']
